Overview

HCV Treatment in HIV Co-Infected Patients in Asia

Status:
Completed

Trial end date:
2016-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the effectiveness and tolerability of hepatitis C virus (HCV) treatment in HIV co-infected patients in routine health care services in Asia through a pilot model of care for treatment of HCV in resource-limited settings.

Phase:

Phase 4

Details

Lead Sponsor:

amfAR, The Foundation for AIDS Research

Collaborator:

Kirby Institute

Treatments:

Interferons
Ribavirin